IMPORTANCE Understanding the role of vitamin D-which regulates inflammatory responses-in noninfectious uveitis (an inflammatory disease) may provide insight into treatment and prevention of this disease.
N oninfectious uveitis is largely a T-cell-mediated disease. 1 The vitamin D receptor is present on most types of immune cells, including T lymphocytes. 2, 3 In mouse studies, treatment with vitamin D prevented or mitigated uveitis. 4 A previous study demonstrated an association between hypovitaminosis D and the presence of noninfectious anterior uveitis in a relatively small sample at a single geographic location. 5 To confirm this observation, we conducted a case-control study in a large population from across the United States.
Methods
Our study involved patients enrolled from January 1, 2000, to December 31, 2016, in the Clinformatics Data Mart Database (OptumInsight), which contains the deidentified claims of beneficiaries from a large private insurer. The institutional review boards of the Massachusetts Eye and Ear Infirmary and the University of Pennsylvania deemed this study exempt from review and waived the need for patient informed consent because the data were deidentified. In this retrospective case-control study, case patients were 18 years or older and had received a diagnosis of uveitis from an eye care clinician followed by a second uveitis diagnosis within 120 days of the initial diagnosis (to confirm that the diagnosis was not made simply to rule out uveitis; see Table 1 for all diagnosis codes used in this study). The date of the first diagnosis was the index date. Cases were also required to have at least 1 vitamin D level determined within 1 year before the index date; the laboratory blood sample obtained closest to the index date was used for analysis. Potential cases were excluded for having less than 24 months of data in the database before the index date, having a systemic disease, or receiving medication (phenobarbital, orlistat, phenytoin, or corticosteroids) known to decrease vitamin D levels. To further reduce miscategorization of noninfectious uveitis, patients who had intraocular surgery within the 90 days before the index date or who received a diagnosis of an infectious systemic disease or infectious uveitis at any time were also excluded (Table 1) .
Five controls were matched to each case using age (±3 years), sex, and race/ethnicity because these demographic factors have been associated with both vitamin D levels and uveitis.
6-10 A 5:1 ratio was chosen because power did not increase substantially for higher ratios. Controls were required to have been examined by an eye care clinician before the index date of the matched case. The same exclusion criteria were applied to cases and controls, except that controls were allowed to have a vitamin D level determined up to 6 months after the index date of the matched case (instead of only before that date). This was done because vitamin D was not a predictive factor of disease for controls, and we wanted to maximize the power of our statistical analysis. The primary outcome assessed the association of noninfectious uveitis with hypovitaminosis D. Vitamin D was evaluated as a dichotomous variable, with a 25-hydroxy vitamin D level of 20 ng/mL (to convert to nanomoles per liter, multiply by 2.496) or greater to be considered adequate because that level of vitamin D is sufficient for bone and overall health.
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Conditional logistic regression, adjusted for 2 proxies for sun exposure, was used to assess the association between uveitis and hypovitaminosis D with SAS, version 9.4 (SAS Institute Inc). The 2 proxies of sun exposure were geographic region and month of laboratory blood draw: fewer hours of daylight (November-March) vs regular hours of daylight (April-October). Because of deidentification concerns, the database provides information on geographic regions representing groups of states. The eastern states are grouped into northern and southern blocks, which is optimal for this analysis of vitamin D, but the western states are not divided into north and south. Therefore, for our analyses, we divided the country into 3 regions: Northeast, Southeast and West. In addition, we conducted racestratified analyses and a sensitivity analysis that excluded patients with systemic diseases that are thought to increase vitamin D levels.
Results
Five hundred fifty-eight patients with uveitis were matched with 2790 controls. Among the combined cohort of 3348 patients, who had a mean (SD) age of 58.9 (14.7) years, 2526 (75.4%) were female, and the racial/ethnic distribution in the matched samples was 2022 (60.4%) white, 552 (16.5%) black, 402 (12.0%) Hispanic, 162 (4.8%) Asian, and 210 (6.3%) unknown. Compared with patients with noninfectious uveitis who did not have a vitamin D level determined within 1 year before diagnosis, patients included in the study were older (58.9 vs 52.4 years), more likely to be female (75.4% vs 54.1%), and more likely to be nonwhite (39.6% vs 33.1%) (P < .001 for all comparisons). No imbalances were seen between cases and matched controls with respect to demographic characteristics ( Table 2) . Table 3 presents the association results. Overall, patients with an adequate vitamin D level had 21% lower odds of having uveitis compared with patients with low vitamin D levels (odds ratio [OR], 0.79; 95% CI, 0.62-0.99; P = .04). In the race-stratified analysis, the association between low vitamin D levels and having uveitis was significant among black patients (OR, 0.49; 95% CI, 0.30-0.80; P = .004) and was nonsignificant but qualitatively similar in white patients (OR, 0.87; 95% CI, 0.62-1.21; P = .40) and Hispanic patients (OR, 0.60; 95% CI, 0.33-1.10; P = .10). In the sensitivity analysis of the 481 cases
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and 2058 controls without any systemic diseases thought to increase vitamin D levels, patients with an adequate vitamin D level had 25% lower odds of having uveitis (OR, 0.75; 95% CI, 0.58-0.97; P = .03).
Discussion
In this study, noninfectious uveitis was found to be associated with hypovitaminosis D. Because cases had their vitamin D level determined within 1 year before the index date, this association might indicate a causal role of low levels of vitamin D in the development of uveitis. A number of immunomodulatory mechanisms could explain these findings, including the ability of vitamin D to upregulate antiinflammatory type 2 helper T cells and suppress inflammatory cytokine activity.
Smaller investigations have shown associations between hypovitaminosis D and specific uveitis subtypes. 5, [12] [13] [14] This larger study confirms earlier findings. It also provides some suggestion that race/ethnicity might affect the association between vitamin D level and noninfectious uveitis. When different racial/ethnic factors were evaluated, we found that the association between low vitamin D levels and noninfectious uveitis was statistically significant only for black patients. This finding could indicate a stronger biological effect of vitamin D on uveitis in this race, or it might indicate limited power to detect a similar difference in the other racial/ethnic groups, especially given that an earlier report 5 found the same association in a population that was mostly white. The effect of race on the association between low vitamin D levels and noninfectious uveitis is an important area for future investigation.
Limitations
Limitations of our study include our inability to assess supplemental use of vitamin D. Although vitamin D levels were determined more than once, we did not believe that these data would be a reliable surrogate for assessing vitamin D supplementation. Some patients with hypovitaminosis D might have started receiving vitamin D supplementation shortly after vitamin D levels were determined, which might have changed vitamin D levels by the index date and resulted in a miscategorization of such patients as having low levels of vitamin D. However, such a bias would be toward the null and would suggest that our results may underestimate the true association between hypovitaminosis D and uveitis. The retrospective case-control design of our study, compared with prospective designs, is less reliable for establishing causality. Use of an extant data set prevented our study from accounting for smoking history (which was unavailable in the data set) and prevented confirmation of the uveitis diagnosis by medical record review. Only 3% to 5% of patients in this database had vitamin D levels determined. Patients typically have vitamin D levels determined as part of preventive primary care or because of a medical indication, such as metabolic bone disease or nutrient absorption problems. While patients with data on vitamin D level are therefore likely to differ from the general population by being more compliant with primary care or having one of the conditions listed above, such differences should affect cases and controls equally, which would also affect the generalizability of our findings but not their validity.
Conclusions
This large national study suggests that hypovitaminosis D might increase the risk of uveitis. Prospective studies are needed to better evaluate causality. If causality were to be established, vitamin D supplementation would be an attractive potential adjunct intervention in the treatment of noninfectious uveitis. Role of the Funder/Sponsor: The funding organizations had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
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